Jump to content
Health NZ Taranaki Lab Manual

Coagulation reference ranges: Difference between revisions

No edit summary
mNo edit summary
 
(2 intermediate revisions by the same user not shown)
Line 18: Line 18:
|g/L
|g/L
|1.5-4.0
|1.5-4.0
|N/A
| rowspan="6" |
|-
|-
|TCT
|TCT
|Seconds
|Seconds
|< 21
|< 21
|N/A
|-
|-
|TCT + PRSO4
|TCT + PRSO4
|Seconds
|Seconds
|< 25
|< 25
|N/A
|-
|-
|D DIMER <50yrs
|D-dimer <50yrs
|ug/L
|ug/L
|< 500
|< 500
|N/A
|-
|-
|D DIMER >50yrs
|D-dimer >50yrs
|ug/L
|ug/L
|Decade x 10
|Decade x 10
|N/A
|-
|-
|FVIII
|FVIII
|iu/dl
|iu/dl
|50 - 150
|50 - 150
|N/A
|}
|}
<nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small>
<nowiki>*</nowiki><small>The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.</small>
<small>References:</small>
<small>Northern Haematology Quality Assurance Group. (2017). ''Consensus guidelines: Haematology reference ranges'' (Version 1.0).</small>

Latest revision as of 15:52, 17 November 2026

Parameter Units Normal range Therapeutic range
INR Ratio 0.8 - 1.2 2.0 - 3.0*
APTT Seconds 24-38 50 - 85 secs
FIBRINOGEN g/L 1.5-4.0
TCT Seconds < 21
TCT + PRSO4 Seconds < 25
D-dimer <50yrs ug/L < 500
D-dimer >50yrs ug/L Decade x 10
FVIII iu/dl 50 - 150

*The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.


References:

Northern Haematology Quality Assurance Group. (2017). Consensus guidelines: Haematology reference ranges (Version 1.0).